Autophagy and cancer

被引:13
作者
Karakas, Hacer Ezgi [1 ]
Gozuacik, Devrim [1 ]
机构
[1] Sabanci Univ, Fac Engn & Nat Sci, Mol Biol Genet & Bioengn Program, Istanbul, Turkey
关键词
Autophagy; stress; cancer; tumor; oncogenes; tumor suppressors; metastasis; cell death; chemotherapy; INTERACTING FACTOR-I; CHAPERONE-MEDIATED AUTOPHAGY; TUMOR-SUPPRESSOR GENE; UNC-51-LIKE KINASE 1; INDUCED CELL-DEATH; DECREASED EXPRESSION; REGULATES AUTOPHAGY; POOR-PROGNOSIS; BREAST-CANCER; COLON-CANCER;
D O I
10.3906/biy-1408-16
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Autophagy is an evolutionary conserved intracellular degradation and stress response mechanism that is mainly responsible for the breakdown and recycling of cytoplasmic materials, including long-lived proteins, protein aggregates, and damaged organelles. In this way, autophagy provides the cell with building blocks and allows the maintenance of homeostasis under stress conditions such as growth factor deficiency, nutrient deprivation, hypoxia, and toxins. Consequently, abnormalities of autophagy contribute to a number of pathologies ranging from neurodegenerative diseases to cancer. Autophagy was reported to have a dual role in cancer. Depending on cancer stage, autophagy seems to act as tumor suppressor or as a mechanism supporting tumor growth and spread. In this review, we provide a summary of the relevant literature and discuss the role of autophagy in cancer formation and chemotherapy responses.
引用
收藏
页码:720 / 739
页数:20
相关论文
共 221 条
  • [11] Inhibition of GATE-16 attenuates ATRA-induced neutrophil differentiation of APL cells and interferes with autophagosome formation
    Brigger, Daniel
    Torbett, Bruce E.
    Chen, Joy
    Fey, Martin F.
    Tschan, Mario P.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 438 (02) : 283 - 288
  • [12] Rab7: A key to lysosome biogenesis
    Bucci, C
    Thomsen, P
    Nicoziani, P
    McCarthy, J
    van Deurs, B
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (02) : 467 - 480
  • [13] Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance
    Carew, Jennifer S.
    Nawrocki, Steffan T.
    Kahue, Charissa N.
    Zhang, Hui
    Yang, Chunying
    Chung, Linda
    Houghton, Janet A.
    Huang, Peng
    Giles, Francis J.
    Cleveland, John L.
    [J]. BLOOD, 2007, 110 (01) : 313 - 322
  • [14] Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation
    Carew, Jennifer S.
    Medina, Ernest C.
    Esquivel, Juan A., II
    Mahalingam, Devalingam
    Swords, Ronan
    Kelly, Kevin
    Zhang, Hui
    Huang, Peng
    Mita, Alain C.
    Mita, Monica M.
    Giles, Francis J.
    Nawrocki, Steffan T.
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (10) : 2448 - 2459
  • [15] The interplay between NLRs and autophagy in immunity and inflammation
    Carneiro, Leticia A. M.
    Travassos, Leonardo H.
    [J]. FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [16] Truncating mutations of RB1CC1 in human breast cancer
    Chano, T
    Kontani, K
    Teramoto, K
    Okabe, H
    Ikegawa, S
    [J]. NATURE GENETICS, 2002, 31 (03) : 285 - 288
  • [17] Autophagy Inhibition Augments the Anticancer Effects of Epirubicin Treatment in Anthracycline-Sensitive and -Resistant Triple-Negative Breast Cancer
    Chittaranjan, Suganthi
    Bortnik, Svetlana
    Dragowska, Wieslawa H.
    Xu, Jing
    Abeysundara, Namal
    Leung, Amy
    Go, Nancy E.
    DeVorkin, Lindsay
    Weppler, Sherry A.
    Gelmon, Karen
    Yapp, Donald T.
    Bally, Marcel B.
    Gorski, Sharon M.
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (12) : 3159 - 3173
  • [18] Cho DH, 2012, ANTICANCER RES, V32, P4091
  • [19] Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer
    Choi, Junjeong
    Jung, Woohee
    Koo, Ja Seung
    [J]. HISTOPATHOLOGY, 2013, 62 (02) : 275 - 286
  • [20] AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
    Chresta, Christine M.
    Davies, Barry R.
    Hickson, Ian
    Harding, Tom
    Cosulich, Sabina
    Critchlow, Susan E.
    Vincent, John P.
    Ellston, Rebecca
    Jones, Darren
    Sini, Patrizia
    James, Dominic
    Howard, Zoe
    Dudley, Phillippa
    Hughes, Gareth
    Smith, Lisa
    Maguire, Sharon
    Hummersone, Marc
    Malagu, Karine
    Menear, Keith
    Jenkins, Richard
    Jacobsen, Matt
    Smith, Graeme C. M.
    Guichard, Sylvie
    Pass, Martin
    [J]. CANCER RESEARCH, 2010, 70 (01) : 288 - 298